Company Overview

Company name: TerrAscend (CNQ: TER)
Description: TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of patients. It also provides education and support programs to physicians and patients through healthcare professionals. It has one operating segment, being the Cultivation and Sale of Cannabis, with subsidiaries located in Canada and the United States.
Year founded: 2017
Parent company:
Industry: Healthcare | Group: | Code:
Employees: 36
City: Mississauga
State: Ontario
Country: Canada

Financial Highlights

Start up capital raised (USD Million): 204.56
Business status: Generating Revenue/Not Profitable
Ownership: Publicly Held
Exchange: CNQ
Ticker: TER
Revenue (USD Million): 79.02
Gross profit (USD Million): 23.00
Net income (USD Million) -164.28
Enterprise value: 154.53
Earnings before interest, tax, depreciation and amortization (EBITDA): -145.26
Fiscal period: TTM 1Q2020
Financing Status: The company (CNQ: TER) is in talks to receive $37 million of development capital from undisclosed investors through a private placement as of May 19, 2020. The company closed the first tranche of the offering on May 25, 2020 raising $27.3 million. The company closed the second tranche issuing 3,561 Units at an issue price of US$2,000 per Unit resulting in proceeds of $7.1 million on May 28, 2020. The Company intends to use the proceeds from the offering to fund company’s growth initiatives including its U.S. expansion strategy, capital expenditures, working capital, and general corporate purposes. Previously, the company (CNQ: TER) received CAD 33.5 million of development capital from Entourage Effect Capital and other undisclosed investors on January 13, 2020 through a private placement.
Number of active investors:
Profile last updated: 04-Jun-2020
Last known valuation:
Last known valuation date: 11-Dec-2017